432702
5/24
© 2024 Novartis
Novartis Pharmaceuticals Corporation
East Hanover, New Jersey 07936-1080
Indication
What is KESIMPTA (ofatumumab) injection?
KESIMPTA is a prescription medicine used to treat adults with relapsing forms of multiple sclerosis (MS) 
including clinically isolated syndrome (CIS), relapsing-remitting disease, and active secondary  
progressive disease. 
It is not known if KESIMPTA is safe or effective in children.
Important Safety Information
Who should not take KESIMPTA?
Do NOT take KESIMPTA if you:
 • have an active hepatitis B virus (HBV) infection.
 • have had an allergic reaction to ofatumumab or life-threatening injection-related reaction to KESIMPTA.
MS, multiple sclerosis; RMS, relapsing multiple sclerosis.  
 *After 3 weekly starter doses; typical administration time when ready to inject.
Jamie-Lynn takes KESIMPTA® for her RMS in less than 1 minute a month,* 
when ready. Whether she’s at home with the kids or on the go for work,  
it fits into her busy schedule—which is just one of the reasons she 
switched to KESIMPTA.
—JAMIE-LYNN SIGLER
Mom, Actor, MS Advocate 
Switched to KESIMPTA in 2023
Scan to learn 
more about taking 
KESIMPTA
TIME
WITH KESIMPTA FOR RMS,
“I CAN FILL
MY WAY.”

View this content as a flipbook by clicking here.